missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18123105

ATPB Antibody (OTI4E5), DyLight 350, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-70224UV

Product Code. 18123105

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ATPB Monoclonal specifically detects ATPB in Human, Rat, Canine, Primate, Monkey samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ATPB
Monoclonal
DyLight 350
50mM Sodium Borate with 0.05% Sodium Azide
ATP5F1B
Full length recombinant protein of human ATPB (NP_001677) produced in HEK293T cells.
0.1 mL
506.0
Store at 4°C in the dark.
Western Blot, Flow Cytometry, Immunocytochemistry, Immunofluorescence
OTI4E5
Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence
ATP synthase subunit beta, mitochondrial, ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide, ATPMB, ATPSBmitochondrial ATP synthase beta subunit, EC 3.6.3, EC 3.6.3.14, MGC5231, mitochondrial ATP synthetase, beta subunit
Mouse
Affinity Purified
Primary
Human, Rat, Canine, Primate, Monkey
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.